Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Profit After Tax (2019 - 2025)

Burning Rock Biotech has reported Profit After Tax over the past 7 years, most recently at -$2.2 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 80.26% year-over-year to -$2.2 million; the TTM value through Dec 2025 reached -$7.8 million, up 83.79%, while the annual FY2025 figure was -$7.9 million, 83.33% up from the prior year.
  • Profit After Tax for Q4 2025 was -$2.2 million at Burning Rock Biotech, up from -$2.4 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$1.4 million in Q2 2025 and troughed at -$41.2 million in Q1 2022.
  • A 5-year average of -$20.8 million and a median of -$23.4 million in 2023 define the central range for Profit After Tax.
  • Biggest five-year swings in Profit After Tax: crashed 247.3% in 2021 and later skyrocketed 90.89% in 2025.
  • Year by year, Profit After Tax stood at -$39.4 million in 2021, then increased by 20.45% to -$31.4 million in 2022, then grew by 27.12% to -$22.8 million in 2023, then soared by 51.26% to -$11.1 million in 2024, then surged by 80.26% to -$2.2 million in 2025.
  • Business Quant data shows Profit After Tax for BNR at -$2.2 million in Q4 2025, -$2.4 million in Q3 2025, and -$1.4 million in Q2 2025.